FDA Updates Analysis of Medical Device Reports of Breast Implant Illness, Breast Implant-Associated Lymphoma
August 24, 2020
Silver Spring, MD – The U.S. Food and Drug Administration (FDA) is providing an update on adverse events reported to the Agency related to breast implants, including breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), and systemic signs and symptoms referred to by patients as breast implant illness (BII), which some patients report after receiving breast implants.
FDA also announces Qualification of a Medical Device Development Tool to Aid in the Effectiveness Assessment of Devices Used in Breast Reconstruction. (FDA)
Hard to treat Chest Pain may be improved with a Patient’s own Stem Cells according to American Heart Association
July 20, 2016
Phoenix, AZ – A non-surgical treatment that uses a patient’s own bone marrow stem cells to treat chest pain or angina improved both symptoms and the length of time treated patients could be physically active, according to preliminary research presented at the American Heart Association’s Basic Cardiovascular Sciences 2016 Scientific Sessions.
Angina is chest pain or discomfort caused when the heart does not get enough oxygen-rich blood due to narrowing or blockages in the arteries leading to the heart.
A patient’s own stem cells may treat chest pain that cannot be treated with current therapies. (American Heart Association)
